Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7362)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2015 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun HZ, Shi H, Zhang SC, Shen XZ. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3. World J Gastroenterol 2015; 21(2): 699-703 [PMID: 25593501 DOI: 10.3748/wjg.v21.i2.699] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i2/699.htm |
| Number | Citing Articles |
| 1 |
雅萍 赵. Effects of Combined Treatment with Transmentil and Ursofalk on Liver Function and Perinatal Prognosis in Pregnant Women with Intrahepatic Cholestasis of Pregnancy. Nursing Science 2019; 8(06): 404 doi: 10.12677/NS.2019.86074
|
| 2 |
Fei Qiao, Feng Ren, Weiting Lu, Haoran Yang, Guiling Mo, Shuangshuang Wang, Lina Liu, Xiangtao Xu. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report. BMC Medical Genomics 2023; 16(1) doi: 10.1186/s12920-023-01602-y
|
| 3 |
Vlasia Kastrinou-Lampou, Raquel Rodríguez-Pérez, Birk Poller, Felix Huth, Zsuzsanna Gáborik, Beáta Mártonné-Tóth, Csilla Temesszentandrási-Ambrus, Heiko S. Schadt, Gerd A. Kullak-Ublick, Michael Arand, Gian Camenisch. Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC). Archives of Toxicology 2024; 98(10): 3409 doi: 10.1007/s00204-024-03794-3
|
| 4 |
Mona Fathy, Manal Kamal, Marwa Al-Sharkawy, Hanaa Al-Karaksy, Nora Hassan. Molecular characterization of exons 6, 8 and 9 of ABCB4 gene in children with Progressive Familial Intrahepatic Cholestasis type 3. Biomarkers 2016; 21(7): 573 doi: 10.3109/1354750X.2016.1166264
|
| 5 |
Zhaoyue Wang, Fan Yang, Jianshe Wang, Xiong Ma. A Novel Mutation of ABCB4 in Progressive Familial Intrahepatic Cholestasis 3. Journal of Clinical Gastroenterology 2016; 50(4): 353 doi: 10.1097/MCG.0000000000000474
|
| 6 |
Kan He, Lining Cai, Qin Shi, Hao Liu, Thomas F. Woolf. Inhibition of MDR3 Activity in Human Hepatocytes by Drugs Associated with Liver Injury. Chemical Research in Toxicology 2015; 28(10): 1987 doi: 10.1021/acs.chemrestox.5b00201
|
| 7 |
Zhenping Wu, Siying Zhang, Lunli Zhang, Ming Li. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report. Diagnostic Pathology 2020; 15(1) doi: 10.1186/s13000-020-00955-7
|
| 8 |
Rong Chen, Feng-Xia Yang, Yan-Fang Tan, Mei Deng, Hua Li, Yi Xu, Wen-Xian Ouyang, Yuan-Zong Song. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures. Orphanet Journal of Rare Diseases 2022; 17(1) doi: 10.1186/s13023-022-02597-y
|